Ameriprise’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXP
BGI
Ameriprise's NRXP Position: Q3 2026 in Review
Ameriprise increased its NRX Pharmaceuticals (NRXP) stake by 52% in Q3 2026, buying an estimated $1.73M and bringing the position to 1,415,212 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.
Ameriprise first reported a position in NRXP in Q2 2026 and has held it in 2 quarters since. 50 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.
- Ameriprise held 1,415,212 shares of NRX Pharmaceuticals worth $4.13M as of Q3 2026.
- Ameriprise bought 486,484 NRX Pharmaceuticals shares in Q3 2026, an estimated $1.73M.
- NRX Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2669 holding.
- Ameriprise first reported a position in NRX Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 50 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.